Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,272) with videos related to
Page
of 128
Sort By:
Translational Psychiatry
|
August 23, 2025
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms
Trevor F Williams, James M Gold, James A Waltz, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
November 24, 2025
Beyond counting clicks: rethinking engagement in digital mental health
Andrea Cipriani, Thomas Ward, Sinéad Lambe, et al.
NPJ Digital Medicine
|
July 3, 2025
Engagement and attrition in digital mental health: current challenges and potential solutions
Katharine A Smith, Thomas Ward, Sinéad Lambe, et al.
Biological Psychiatry
|
September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Michael F Green, Keith H Nuechterlein, James M Gold, et al.
The American Journal of Psychiatry
|
April 3, 2008
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Robert Freedman, Ann Olincy, Robert W Buchanan, et al.
Brain : a Journal of Neurology
|
April 18, 2024
Different learning aberrations relate to delusion-like beliefs with different contents
Rosa Rossi-Goldthorpe, Steven M Silverstein, James M Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 15, 2021
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance
Kathleen M Zackowski, Jennifer Freeman, Giampaolo Brichetto, et al.
Cell Reports
|
October 24, 2019
T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis
Caren Ramien, Erik C Yusko, Jan Broder Engler, et al.
NPJ Schizophrenia
|
May 18, 2021
Increased face detection responses on the mooney faces test in people at clinical high risk for psychosis
Steven M Silverstein, Judy L Thompson, James M Gold, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Page
of 128
Search research articles
Search
Showing results (991-1000 of 1,272) with videos related to
Sort By:
Page
of 128
Translational Psychiatry
|
August 23, 2025
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms
Trevor F Williams, James M Gold, James A Waltz, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
November 24, 2025
Beyond counting clicks: rethinking engagement in digital mental health
Andrea Cipriani, Thomas Ward, Sinéad Lambe, et al.
NPJ Digital Medicine
|
July 3, 2025
Engagement and attrition in digital mental health: current challenges and potential solutions
Katharine A Smith, Thomas Ward, Sinéad Lambe, et al.
Biological Psychiatry
|
September 1, 2004
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
Michael F Green, Keith H Nuechterlein, James M Gold, et al.
The American Journal of Psychiatry
|
April 3, 2008
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Robert Freedman, Ann Olincy, Robert W Buchanan, et al.
Brain : a Journal of Neurology
|
April 18, 2024
Different learning aberrations relate to delusion-like beliefs with different contents
Rosa Rossi-Goldthorpe, Steven M Silverstein, James M Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 15, 2021
Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance
Kathleen M Zackowski, Jennifer Freeman, Giampaolo Brichetto, et al.
Cell Reports
|
October 24, 2019
T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis
Caren Ramien, Erik C Yusko, Jan Broder Engler, et al.
NPJ Schizophrenia
|
May 18, 2021
Increased face detection responses on the mooney faces test in people at clinical high risk for psychosis
Steven M Silverstein, Judy L Thompson, James M Gold, et al.
Archives of General Psychiatry
|
June 6, 2007
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
Richard S E Keefe, Robert M Bilder, Sonia M Davis, et al.
Page
of 128